Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Expert Review of Anticancer Therapy
|
April 13, 2019
Rucaparib in the landscape of PARP inhibition in ovarian cancer
Emeline Colomba, Patricia Pautier, Fanny Pommeret, et al.
Bulletin Du Cancer
|
December 17, 2024
[Survival after cancer on Reunion Island]
Mohamed Khettab, Franck Ah-Pine, Emeline Colomba, et al.
Bulletin Du Cancer
|
March 12, 2025
Mohamed Khettab, Franck Ah-Pine, Emeline Colomba, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 4, 2026
Role of <sup>18</sup>F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy
Alexandra Paule, Soizic Masson, Johan Rose Dite Modestine, et al.
Therapeutic Advances in Medical Oncology
|
January 25, 2021
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
Pernelle Lavaud, Clément Dumont, Constance Thibault, et al.
Oncotarget
|
December 21, 2020
Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma
Annalisa Guida, Gwénaël Le Teuff, Carolina Alves, et al.
Bulletin Du Cancer
|
June 27, 2022
Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma
Ronan Flippot, Violaine Gorgeu, Marc Pujalte, et al.
Clinical Genitourinary Cancer
|
July 23, 2020
Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study
Francesco Massari, Vincenzo Di Nunno, Annalisa Guida, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2020
Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome
Emeline Colomba, Grégoire Marret, Giulia Baciarello, et al.
Clinical Genitourinary Cancer
|
May 1, 2020
Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial
Clément Dumont, Giulia Baciarello, Pierre-Olivier Bosset, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Expert Review of Anticancer Therapy
|
April 13, 2019
Rucaparib in the landscape of PARP inhibition in ovarian cancer
Emeline Colomba, Patricia Pautier, Fanny Pommeret, et al.
Bulletin Du Cancer
|
December 17, 2024
[Survival after cancer on Reunion Island]
Mohamed Khettab, Franck Ah-Pine, Emeline Colomba, et al.
Bulletin Du Cancer
|
March 12, 2025
Mohamed Khettab, Franck Ah-Pine, Emeline Colomba, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 4, 2026
Role of <sup>18</sup>F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy
Alexandra Paule, Soizic Masson, Johan Rose Dite Modestine, et al.
Therapeutic Advances in Medical Oncology
|
January 25, 2021
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
Pernelle Lavaud, Clément Dumont, Constance Thibault, et al.
Oncotarget
|
December 21, 2020
Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma
Annalisa Guida, Gwénaël Le Teuff, Carolina Alves, et al.
Bulletin Du Cancer
|
June 27, 2022
Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma
Ronan Flippot, Violaine Gorgeu, Marc Pujalte, et al.
Clinical Genitourinary Cancer
|
July 23, 2020
Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study
Francesco Massari, Vincenzo Di Nunno, Annalisa Guida, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2020
Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome
Emeline Colomba, Grégoire Marret, Giulia Baciarello, et al.
Clinical Genitourinary Cancer
|
May 1, 2020
Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial
Clément Dumont, Giulia Baciarello, Pierre-Olivier Bosset, et al.
Page
of 7